AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
TrxR↓, AntiCan↑, TumCG↓, Apoptosis↑, necrosis↑, cl‑PARP↑, MMP↓, ROS↑, GSH↓, eff↓,
| - |
in-vitro, |
GBM, |
U251 |
|
|
|
- |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
GBM, |
GL26 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
CRC, |
RKO |
|
|
|
AntiCan↑, eff↑, EPR↑, selectivity↑, ROS↑, Casp↑, Apoptosis↑, DNAdam↑, tumCV↓, eff↑,
AntiCan↑, selectivity↑,
AntiCan↑, TumCP↓, Apoptosis↑, Casp3↑, Casp9↑, cl‑PARP↑, TumCD↑, DNAdam↑,
TumCP↓, Apoptosis↑, RadioS↑, ChemoSen↑, *antiOx↑, *Inflam↓, *Bacteria↓, *AntiViral↑, *AntiDiabetic↑, *neuroP↑, AntiCan↑, TumCG↓, TumCI↓, TumCCA↑, cl‑PARP↑, selectivity↑, CycB/CCNB1↓, CDK1↓, p‑cDC2↓, p‑ERK↓, p‑p38↑, p‑JNK↑, MMP9↓, TIMP1↑, BioAv↓, BioAv↑, Half-Life↑,
AntiCan↑, chemoPv↑, TRAIL↑, selectivity↑, toxicity↓, MMP↓, Apoptosis↑,
AntiCan↑, TrxR1↓, TrxR2↓, ROS↑, Apoptosis↑, eff↓, eff↑,
| - |
in-vitro, |
Cerv, |
INT-407 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, TumCG↓, ROS↑, Apoptosis↑, TumCMig↓, CTNNB1↓, Twist↓, Bcl-2↓, survivin↓, NF-kB↓, Sp1/3/4↓, BAX↑, P21↑, P53↑, eff↓, TumCMig↓,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GSH↓, 1, ROS↑, 4, TrxR↓, 1, TrxR1↓, 1, TrxR2↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 2,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 7, BAX↑, 1, Bcl-2↓, 1, Casp↑, 1, Casp3↑, 1, Casp9↑, 1, p‑JNK↑, 1, necrosis↑, 1, p‑p38↑, 1, survivin↓, 1, TRAIL↑, 1, TumCD↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Sp1/3/4↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 2, P53↑, 1, cl‑PARP↑, 3,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↓, 1, CycB/CCNB1↓, 1, P21↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑cDC2↓, 1, CTNNB1↓, 1, p‑ERK↓, 1, TumCG↓, 3,
Migration(tgid=13) ⓘ
MMP9↓, 1, TIMP1↑, 1, TumCI↓, 1, TumCMig↓, 2, TumCP↓, 2, Twist↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EPR↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 1, eff↓, 3, eff↑, 3, Half-Life↑, 1, RadioS↑, 1, selectivity↑, 4,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 8, chemoPv↑, 1, toxicity↓, 1,
Total Targets: 50
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, neuroP↑, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiViral↑, 1, Bacteria↓, 1,
Total Targets: 6
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page